800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Treatment for opioid use disorder in Baltimore
Baltimore has lived with the worst overdose crisis of any major American city, and that history shapes how treatment is delivered here. The city sits inside one of the densest networks of opioid treatment programs (OTPs) and office-based providers in the country, with hospital systems, federally qualified health centers, and independent clinics offering all three FDA-approved medications. The listings above show clinics serving Baltimore City and the surrounding area. If you want to talk to someone now, call any provider on this page directly, or call the helpline.
The three medications, and where each is offered
Three medications are approved to treat opioid use disorder, sometimes called medication-assisted treatment (MAT) or medications for opioid use disorder (MOUD). The setting where you can get each one is different.
Methadone is a full opioid agonist that prevents withdrawal and blocks the effect of other opioids when dosed correctly. For opioid use disorder, federal law allows methadone to be dispensed only through a licensed opioid treatment program, not a regular pharmacy. Most people start with daily visits to the clinic and earn take-home doses as treatment stabilizes.
Buprenorphine, including the buprenorphine-naloxone combination sold as Suboxone and the monthly extended-release injection Sublocade, is a partial agonist with a ceiling effect that lowers overdose risk at higher doses. Since the federal X-waiver was eliminated in 2023, any clinician with a standard DEA registration that includes Schedule III authority can prescribe buprenorphine in an office and have it filled at a pharmacy. It is also offered inside OTPs. How methadone and buprenorphine compare goes into more depth on the trade-offs.
Naltrexone, including the monthly Vivitrol injection, blocks opioid effects but cannot be started until a person has been off all opioids for a period set by the clinician, usually about a week, to avoid sudden, severe withdrawal. Any licensed prescriber can write it.
Starting treatment, and what intake looks like
Calling a clinic is the first step. Same-day or next-day intakes are common in Baltimore, particularly at OTPs and at hospital-based bridge clinics that start buprenorphine in the emergency department and hand off to longer-term care. Bring a photo ID and your insurance card if you have one, but missing paperwork is not a reason to delay calling. An intake includes a medical history, a physical assessment, drug testing, and a conversation about which medication fits your situation.
One specific caution if you have been using fentanyl: starting Suboxone too soon after a recent fentanyl dose can trigger sudden, severe symptoms (precipitated withdrawal). Fentanyl lingers in the body longer than heroin, so clinicians often time the first dose carefully, use a low-dose induction approach, or start with methadone instead. This is a conversation to have with the intake clinician rather than a reason to delay treatment. Methadone treatment for fentanyl addiction covers the trade-offs in more detail.
Take-home doses, telehealth, and what the current rules allow
SAMHSA’s 2024 revision of the federal OTP rules (42 CFR Part 8) made several pandemic-era flexibilities permanent. Stable patients can now receive up to a 28-day supply of methadone take-homes on a graduated schedule, treatment can be started by telehealth (audio-visual for methadone, audio-only or audio-visual for buprenorphine), and the prior requirement of a one-year history of addiction before OTP admission was removed.
For buprenorphine specifically, the DEA and HHS extended the broader COVID-era telemedicine flexibilities through December 31, 2026, while a permanent buprenorphine telemedicine final rule that took effect December 31, 2025 sets the long-term framework. As of June 2026, you can start buprenorphine through a telehealth visit, including by phone in many cases, without a prior in-person appointment. These rules are still being finalized, so confirm what is current with the provider. Why staying with your dose matters talks through what stable treatment looks like over time.
Paying for care in Baltimore
Most clinics on this page accept Maryland Medicaid, private insurance, Medicare, and self-pay; some operate on a sliding scale. Maryland Medicaid is delivered through HealthChoice, the state’s managed care program administered by the Maryland Department of Health. Substance use disorder services are carved out of managed care and administered statewide through Carelon Behavioral Health, which functions as Maryland’s behavioral health administrative services organization. Methadone, buprenorphine (including Suboxone), and injectable naltrexone are all covered. The federal requirement that state Medicaid programs cover all three FDA-approved MOUDs was made permanent by the 2024 Consolidated Appropriations Act, so this coverage is not changing in the near term. Ask the clinic directly about prior authorization, co-pays, and whether they bill your specific MCO.
Baltimore’s overdose picture, and what is changing
Baltimore recorded 568 overdose deaths in 2025, including 425 that involved fentanyl, according to the Maryland Department of Health. That is a 27 percent drop from 777 deaths in 2024, which was itself a 25 percent drop from 1,043 deaths in 2023 (Baltimore City Health Department; Maryland Overdose Data Dashboard, 2026). The decline is the largest of any large U.S. county over that span (Centers for Disease Control and Prevention; Baltimore Banner analysis, 2026), and researchers attribute much of it to a disruption in the illicit fentanyl supply alongside widespread naloxone distribution. The crisis is not over: Baltimore still leads U.S. metro areas in overdose mortality, the disparity affecting older Black men remains the steepest in the city, and mass overdose events in the Penn North neighborhood in 2025 showed how quickly the drug supply can shift. Opioid addiction covers the underlying medical picture. The reason this page exists is that treatment works, and starting on medication is the strongest individual protection against another overdose.
Naloxone and overdose response in the city
Naloxone (Narcan) reverses an opioid overdose by restoring breathing. In Maryland, a statewide standing order updated in August 2025 allows any licensed pharmacist to dispense any formulation of naloxone, including supplies for administration, to anyone, with no prescription and no required training (Maryland Department of Health, 2025). Narcan nasal spray is also available over the counter. The Baltimore City Health Department and the Baltimore City Mayor’s Office of Overdose Response (BCMOOR) operate a Naloxone Leave-Behind Program in partnership with the Baltimore City Fire Department, which lets first responders leave naloxone with patients and bystanders at the scene of an overdose call. The Non-Fatal Overdose Spike Alert and Response System dispatches outreach teams to neighborhoods experiencing clusters of overdoses. Maryland’s Good Samaritan law protects people who call 911 or give naloxone during an overdose. A return to use is common during recovery and is not a failure; the safest response is to get back into treatment, not to use alone. Overdose risk and methadone goes into how medication treatment lowers that risk.
Specific situations: reentry, pregnancy, and family support
Maryland House Bill 116, passed in 2019 and now in effect across all 24 counties, requires jails statewide to offer screening and access to all three FDA-approved MOUDs during incarceration and at reentry. Johns Hopkins researchers documented in Health Affairs (2025) that the law has improved continuity of care and reduced post-release overdose risk, though implementation gaps remain. If you are reentering from a Maryland jail or state facility, ask the clinic whether they coordinate with the facility’s reentry team. For pregnant patients, methadone and buprenorphine are the standard of care in pregnancy, and treatment lowers the risk of overdose, miscarriage, and preterm birth. Maryland recognizes a Plan of Safe Care for newborns affected by substance exposure; the law’s intent is care coordination, not punishment, and seeking MOUD during pregnancy is the recommended step. Methadone and pregnancy walks through what to expect. For families, the most useful step is usually helping the person make and keep the first appointment; information for families has more.
Common questions about treatment in Baltimore
Is methadone treatment just trading one drug for another?
No. Methadone is a long-acting medication taken at a steady, prescribed dose that stops withdrawal and cravings without producing a high in someone who is tolerant. Decades of research show it cuts the risk of overdose death roughly in half and improves retention in care. Calling it a replacement misframes how it works medically.
Can I get Suboxone from a regular doctor in Baltimore?
Yes. Since the X-waiver was eliminated in 2023, any clinician with a standard DEA registration that includes Schedule III authority can prescribe buprenorphine and Suboxone in an office setting and have you fill it at a pharmacy. Primary care offices, federally qualified health centers, and addiction medicine practices in the area all do this.
Do I have to go to the clinic every day for methadone?
Most people do at the start. Take-home doses are earned based on stability in treatment, and federal rules now allow up to a 28-day supply for stable patients. The clinic decides eligibility based on factors like dose stability, drug screens, and time in treatment.
Can I start buprenorphine by telehealth?
In most cases, yes. As of June 2026, DEA and HHS rules allow buprenorphine to be started by telehealth, including audio-only in many situations, without a prior in-person visit. Several Maryland providers offer this. The rules are being finalized, so confirm current options with the provider you call.
What if I have used fentanyl recently and want to start Suboxone?
Tell the intake clinician. Fentanyl stays in the body longer than heroin, and starting Suboxone too soon can cause precipitated withdrawal. Clinicians address this by timing the first dose, using a low-dose induction, or starting with methadone instead. This is medically manageable; the worst response is to put off calling.
Will treatment be confidential if I am on probation, parole, or in a custody case?
Medical treatment records are protected by federal law (42 CFR Part 2 and HIPAA). Clinics can share information with referring agencies only with your written consent or under specific legal exceptions.
Sources and review
Last reviewed June 2026. Sources used for this page:
- SAMHSA, “Medications, Counseling, and Related Conditions,” and “42 CFR Part 8 Final Rule” (2024). samhsa.gov/medications-substance-use-disorders
- DEA and HHS, “Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” (effective Jan 1 to Dec 31, 2026) and “Expansion of Buprenorphine Treatment via Telemedicine Encounter” final rule (effective Dec 31, 2025). Federal Register
- Maryland Department of Health, Overdose Data Dashboard and Office of Overdose Response (2026). stopoverdose.maryland.gov
- Baltimore City Health Department, “Baltimore City Overdose Response Needs Assessment” (May 2025) and Naloxone resources. health.baltimorecity.gov
- Maryland Department of Health, Statewide Naloxone Standing Order (Aug 28, 2025).
- Maryland Department of Health, HealthChoice and Carelon Behavioral Health of Maryland (2025).
- Saloner B, Kramer C, Lenz C, et al., “Maryland’s State-Mandated Opioid Treatment in Jails,” Health Affairs (May 2025).
- FDA, MOUD product labels for methadone, buprenorphine, and naltrexone.
Methadone Centers is a directory and education site. It is not a treatment provider and does not provide medical advice, diagnosis, or treatment. The helpline shown on this site is sponsored. Decisions about which medication and setting fit your situation should be made with a licensed clinician.